MedTrace Logo

Pericoital Oral Contraception With Levonorgestrel

NCT00922233 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2013-10-29

Study results available
· View outcomes & findings →

Summary

A prospective, open-label, single arm, multicenter study to evaluate efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel

Conditions

  • Healthy

Interventions

DRUG

levonorgestrel

oral contraceptive pills

Sponsors & Collaborators

  • FHI 360

    lead OTHER

Principal Investigators

  • Vera Halpern, MD · FHI 360

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • United States
  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00922233 on ClinicalTrials.gov